Exparel liposomal

RSS

bupivacaine

Authorised
This medicine is authorised for use in the European Union.

Overview

Exparel liposomal is a local anaesthetic that is used in adults to treat pain after certain operations. It can be used either for local pain relief by injecting it around the edges of small to medium sized surgical wounds or for regional pain relief by injecting it around the nerves that supply the lower limbs or the shoulder. It contains the active substance bupivacaine.

This EPAR was last updated on 10/12/2020

Authorisation details

Product details
Name
Exparel liposomal
Agency product number
EMEA/H/C/004586
Active substance
bupivacaine
International non-proprietary name (INN) or common name
bupivacaine
Therapeutic area (MeSH)
Acute Pain
Anatomical therapeutic chemical (ATC) code
N01BB01
Publication details
Marketing-authorisation holder
Pacira Ireland Limited
Date of issue of marketing authorisation valid throughout the European Union
16/11/2020
Contact address

Pacira Ireland Limited
70 Sir John Rogerson's Quay
Dublin 2 DO2R296
Ireland

Product information

16/11/2020 Exparel liposomal - EMEA/H/C/004586 -

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Amides
  • Anesthetics, local

Therapeutic indication

Exparel is indicated as a brachial plexus block or femoral nerve block for treatment of post-operative pain in adults, and as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds in adults.

Assessment history

How useful was this page?

Add your rating